Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility Study of the Combination of Radiotherapy, Chemotherapy and Hyperthermia for the Treatment of Stage IIB-III-IVA Cervical Cancer
NCT00008112Phase 2Unknown
- Sponsor
- University of Amsterdam
- Start
- Jun 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin in Cervical Cancer (CC), sponsored by University of Amsterdam. Primary endpoints: Feasibility of adding cisplatin and locoregional hyperthermia to radiotherapy, Acute toxicity and 1 more. Status: unknown.
02
Drugs
cisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00008112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008112.